Coordination chemistry
Clicking Fe metallohelices tunes cancer-cell selectivity
Open access · cc by · source: Europe PMC
Copper-click derivatisation of a stable Fe2L3 helix gives Δ-[Fe2L3a3]Cl4, which is more cancer-selective than the parent, hits cancer stem cells, and still has a fully characterised coordination core.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Inspect source passages
Clicking Fe metallohelices tunes cancer-cell selectivity
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
Scratch wounds stayed 62% and 71% open with Δ-[Fe2L13]Cl4 and Δ-[Fe2L3a3]Cl4 versus 33% in the control.
While in a control sample a scratch in a monolayer of HCT116 p53 +/+ cells had healed in 24 h to 33%, the presence of non-toxic doses of Δ-[Fe 2 L 1 3 ]Cl 4 or Δ-[Fe 2 L 3a 3 ]Cl 4 suppressed healing, leaving 62% and 71% respectively of the wound open.
Invasion fell 35% and 58% with the parent and clicked Δ helices.
Using a Matrigel™ transwell assay,, (see ESI) it was shown that while Δ-[Fe 2 L 2 3 ]Cl 4 had no effect, Δ-[Fe 2 L 1 3 ]Cl 4 and Δ-[Fe 2 L 3a 3 ]Cl 4 reduced HCT116 p53 +/+ invasive ability by 35% and 58% [bottom panel in ].
Key findings
Click conversion raised ovarian/breast potency ~7–25-fold. Δ-[Fe2L3a3]Cl4 left 71% of a scratch open versus 33% control, cut invasion 58%, IC50 1.21 μM on CD133+ CSCs, and inhibited Rb+ uptake 35–47%. p53-null cells were not resistant.
Methodology
Authors CuAAC-functionalised triplex alkynyl metallohelices, confirmed products by NMR/MS, then compared enantiomers in cancer versus non-cancer cells, wound-healing, invasion, Na+/K+ ATPase, and CD133+ colonosphere assays.
Limitations
These are cell-based pharmacology endpoints, not a clinical anticancer trial or a solved target co-crystal of the helix with Na+/K+ ATPase.
Related papers in this topic
Same topic cluster — not a recommendation engine.